MedPath

Hemostatic Textile to Control Bleeding at Donor Graft Sites

Completed
Conditions
Wounds
Interventions
Device: Stasilon
Registration Number
NCT00855569
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

The rationale underlying the study is that donor site bleeding is common and often problematic when presenting to the burn surgeon or staff. Frequently, gauze wound dressings are not sufficiently hemostatic to control a donor site bleed thereby leading to administration of vasoconstrictive agents and repeated application of wound dressing/pressure. The hemostatic textile Stasilon™ has proven superior to gauze in reducing bleeding from anesthetized pigs undergoing standardized surgically-induced trauma. Also, observational case reports have noted cessation of bleeding in a limited number of human patients with difficult to control bleeds.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • >/= 18 years old
  • burn injury requiring allografting from donor site
Read More
Exclusion Criteria
  • < 18 years
  • unable to give consent due to mental or emotional instability
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1StasilonEach donor site will act as it own control - both dressings will be applied to the donor site and assessments will be made
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of a new hemostatic textile named Stasilon™ against standard wound dressings in controlling burn patient donor graft site bleeding.At the time of surgery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

North Carolina Jaycee Burn Center

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath